Skip to main content

Global Biological Safety Testing Industry analysis research and trends report for 2017-2025

According to the latest report published by Credence Research, Inc. “Biological Safety Testing Market – (Product Type – Reagents & Kits, Instruments and Services); (Test Type – Sterility Tests, Endotoxin Tests, Cell Line Authentication and Characterization Tests, Residual Host Contaminant Detection Tests, Bioburden Tests, Adventitious Agent Detection Tests, Others Tests); (Application – Gene and Cellular Therapy, Tissue & tissue-based products, Vaccines & therapeutics, Stem Cell Research, and Others): Market Growth, Future Prospects and Competitive Analysis, 2017-2025,” the market was valued at USD 2.15 Bn in 2016, and is expected to reach USD 6.17 Bn by 2025, expanding at a CAGR of 12.3% from 2017 to 2025.
Browse the full report Biological Safety Testing Market: Market Growth, Future Prospects and Competitive Analysis, 2017-2025 report athttp://www.credenceresearch.com/report/biological-safety-testing-market
Market Insights 
Biological safety testing is a mandatory process in pharmaceutical and biotechnology companies for quality control measure for biological and drug manufacturing process. On the basis of products and services the biological safety testing market is segmented into reagents & kits, instruments and services. The reagents & kits held the largest market in the product segment due to repeated use of necessary reagents in the biological safety process. Hence, leading to the higher purchase of reagents and kits. Moreover, introduction of more advanced and modified reagents formulations serving the purpose better are further driving the market. The manufacturing companies are introducing the kits for particular application which has increased the better adaptability of these products in the laboratory setting and toxicology testing making it a more organized market. The most common tests elucidated in this study include sterility tests, endotoxin tests, cell line authentication and characterization tests, residual host contaminant detection tests, bioburden tests, adventitious agent detection tests and others. Sterility testing held the largest market in the overall biological safety testing market due to its wide application in pharmaceutical and biotechnology process. The constant efforts for ensuring drug product quality and safety, health authorities in many countries have implemented, or are considering implementing, quality control (QC) testing requirements for pharmaceuticals, biological/biotechnology, and/or vaccine products entering the market which would drive the biological safety testing market during the forecast period.
The applications mentioned in the biological safety testing market are gene and cellular therapy, tissue & tissue-based products, vaccines & therapeutics, stem cell research and other. Vaccines & therapeutics held the largest share in the application segment. Vaccines and therapeutics administered by the parenteral route are required to be tested for sterility at the final container and also at various stages during manufacture according to the guidelines issued by the FDA and respective authority to prevent toxicity and contaminations. Thus, defined guidelines ensuring the safety of developed vaccines with unaltered therapeutic value and reduced toxicity, which may result from constituent materials and pharmacodynamic action of the vaccine, are presumed to be responsible for the heightened demand of this segment during the forecast period.
Geographically, North America dominated the global biological safety testing market which was followed by Europe. The major factors leading to the dominance of North America are the presence of prominent players in the region with continuous market expansion and evolution. Heightened R&D activities undertaken by the companies with the initiatives by the government further drive the market. Asia Pacific is anticipated to be the fastest growing region the biological safety testing market due to growing healthcare infrastructure resulting in growing R&D investments from the major pharmaceutical giants. Moreover, lower cost of contract research has led to the paradigm shift towards Asia Pacific. In addition, favourable regulatory policies enforced by the healthcare organizations to improve safety, as well as the improving healthcare infrastructure quality is further expected to widen the growth opportunities in the future.
Market Competition Assessment:
The biological safety testing market currently have comprises number of companies such as Thermo Fisher Scientific, Lonza Group, Sigma Aldrich Corporation, Charles River Laboratories International, Inc., and Wuxi Pharmatech, and others currently operating in the market.
ToC
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions
Chapter 2 Executive Summary
2.1 Biological Safety Testing Market Portraiture
2.2 Biological Safety Testing Market, by Product Type, 2016 (US$ Mn)
2.3 Biological Safety Testing Market, by Test Type, 2016 (US$ Mn)
2.4 Biological Safety Testing Market, by Application Type, 2016 (US$ Mn)
2.5 Biological Safety Testing Market, by Geography, 2016 (Value %)
Company Profiles
About Us:
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Contact:
Name: Chris Smith
Designation: Global Sales Manager
Ph: 1-800-361-8290

Comments

Popular posts from this blog

Rigid Plastic Packaging Market – Global Market Size, Share, Trend, Market Growth, Analysis And Industry Forecasts to 2026

The latest market report published by Credence Research, Inc. “Rigid Plastic Packaging Market By Resin Type (Polyethylene, Polyethylene Terephthalate, Polypropylene, Polystyrene, Polyvinyl Chloride, Expanded Polystyrene, Others), By End-use industry (Beverages, Food, Healthcare, Personal Care, Industrial, Others), By Type (Bottles & Jars, Trays, Tubs Cups & Pots, Rigid Bulk Products and Others) and By Region (North America, Europe, Asia Pacific, Latin America, & Middle East & Africa) – Growth, Future Prospects and Competitive Analysis, 2017 – 2025,” the global rigid plastic packaging market was valued at US$ 195.56 Bn in 2016, expanding at a CAGR of 5.7% from 2017 to 2025. Market Insights Rigid plastic packaging possesses features such as lightweight, flexible, and durable, which makes it suitable solution for packaging of products used in different industries such as beverages, food, healthcare, personal care and so on. Rigid plastic packaging products includes bottle…

Global Wound Closure Surgical Products Market is Expected to Reach US$ 26.3 Bn by 2025: Credence Research

The latest market report published by Credence Research, Inc. “Wound Closure Surgical Products Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025” the wound closure surgical products market was valued at US$ 14.5 Bn in 2016 and is expected to reach US$ 26.3 Bn 2025, expanding at a CAGR of 6.8% from 2017 to 2025. Browse the full report Wound Closure Surgical Products Market: Growth, Future Prospects, and Competitive Analysis, 2017 -2025 report at http://www.credenceresearch.com/report/wound-closure-surgical-products-market Market Insights: There is an increase in demand for cost efficient surgical procedures that assist in sealing of tissues and providing complete closure of wounds with total recovery. Wound closure surgical products are available in various forms viz., hemostats, tissue sealants, adhesives, ligating clips, wound closure strips, mechanical stapling device and sutures. Wound closures surgical products are predominantly used for surgical closures which…

Global Automated External Defibrillators Market Projected To Grow At A Significant Rate Of 7.2% From 2017–2025: Credence Research

According to the latest report published by Credence Research, Inc. “Automated External Defibrillators MarketGrowth, Future Prospects and Competitive Analysis, 2017-2025,” the global automated external defibrillators market is projected to grow at a significant rate of 7.2% from 2017-2025. Browse the full report Automated External Defibrillators Market Growth, Future Prospects and Competitive Analysis, 2017-2025 at http://www.credenceresearch.com/report/automated-external-defibrillators-market Market Insights                                                   Automated external defibrillators (AEDs) are portable and lightweight devices that deliver electrical shock to the heart in case of sudden cardiac arrest (SCA). SCA is a condition wherein the heart stops beating unexpectedly, leading to death if not treated at the earliest. According to America Heart Association (AHA), SCA is a leading cause of death globally, accounting for more than 350,000 medical emergencies every year in the …